X4 Pharmaceuticals, Inc.【XFOR】 減価償却費の推移

機能の使い方
(単位:ドル) 減価償却費 前年比(%)
4Q25 223,000 -18.3%
3Q25 223,000 -16.5%
2Q25 355,000 +83.0%
1Q25 476,000 +667.7%
4Q24 273,000 +340.3%
3Q24 267,000 +110.2%
2Q24 194,000 -
1Q24 62,000 -51.2%
4Q23 62,000 -50.0%
3Q23 127,000 -4.5%
4Q22 124,000 -6.1%
3Q22 124,000 -6.1%
2Q22 132,000 +2.3%
1Q22 133,000 +25.5%
4Q21 132,000 +28.2%
3Q21 132,000 -9.6%
2Q21 129,000 +95.5%
1Q21 106,000 +194.4%
4Q20 103,000 +221.9%
3Q20 146,000 +440.7%
2Q20 66,000 +175.0%
1Q20 36,000 +80.0%
4Q19 32,000 -5.9%
3Q19 27,000 -25.0%
2Q19 24,000 -38.5%
1Q19 20,000 -56.5%
4Q18 34,000 -
3Q18 36,000 -
2Q18 39,000 -
1Q18 46,000 -